| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.12 |
32 |
≤0.12 － 64 |
Gentamicin (Gentamycin, Garamycin)  |
89 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
0.5 |
0.125 － 1 |
Quinupristin/Dalfopristin (Synercid) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
0.5 |
0.125 － 1 |
Quinupristin/Dalfopristin (Synercid) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.125 |
2 |
0.125 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.25 |
0.03 － 1 |
Daptomycin + 75 μg/ml Ca++ |
67 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.25 |
0.12 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
0.03 － 8 |
DC-159a |
268 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.06 － 2 |
TAK-599 |
162 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.063 － 2 |
Quinupristin/Dalfopristin (Synercid) |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
0.12 － 0.5 |
Daptomycin (Cubicin) |
16 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
0.5 |
≤0.12 － >4 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
162 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
≤0.06 － 4 |
Ranbezolid (RBX 7644) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
1 |
0.125 － 2 |
Panduratin A |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
2 |
≤0.063 － 2 |
ME1036 |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
2 |
0.125 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.06 － 32 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.12 － >32 |
Gatifloxacin (Tequin) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
4 |
0.25 － 8 |
Levofloxacin (Levaquin, Quixin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
8 |
0.12 － 32 |
Levofloxacin (Levaquin, Quixin) |
117 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>0.25 |
>8 |
0.25 － >8 |
Levofloxacin (Levaquin, Quixin) |
175 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.25 |
32 |
0.12 － 32 |
Levofloxacin (Levaquin, Quixin) |
16 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>0.25 |
>32 |
0.25 － >32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.5 |
0.5 |
0.12 － >1 |
Daptomycin (Cubicin) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.5 |
0.5 |
0.25 － 1 |
Daptomycin (Cubicin) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.5 |
0.5 |
0.25 － 1 |
Daptomycin (Cubicin) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
0.5 |
1 |
0.004 － 1 |
Daptomycin + 50 μg/ml Ca++ |
67 |